Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate th safety and efficacy of one-daily topical application of CLS001 low, mid and high dose compared to vehicle gel in subjects with papulopustular rosacea.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Maruho Co., Ltd.
NCT05675501 · Papulopustular Rosacea
NCT01872715 · Papulopustular Rosacea
NCT03276936 · Papulopustular Rosacea
NCT01494467 · Papulopustular Rosacea
NCT04608500 · Facial Papulopustular Rosacea
Radiant Research Inc.
Birmingham, Alabama
ATS Clinical Research
Santa Monica, California
The Savin Center, PC
New Haven, Connecticut
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions